GetTopicDetailResponse(id=a03d125e0142, topicName=甲烯四氫葉酸脫氫酶2, introduction=, content=舒尼替尼 甲烯四氫葉酸脫氫酶2, image=null, comments=0, allHits=226, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Thu Apr 03 11:52:03 CST 2025, time=2025-04-03, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=503145, tagList=[TagDto(tagId=503145, tagName=甲烯四氫葉酸脫氫酶2)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2258921, encodeId=3cc722589214c, content=<a href='/topic/show?id=3cc88658264' target=_blank style='color:#2F92EE;'>#舒尼替尼#</a> <a href='/topic/show?id=a03d125e0142' target=_blank style='color:#2F92EE;'>#甲烯四氫葉酸脫氫酶2#</a>, objectTitle=Cancer Res：中山大學(xué)黃斌/陳凌武/毛曉鵬/陳俊星研究發(fā)現(xiàn)靶向MTHFD2有望成為克服舒尼替尼耐藥性的有效策略, objectType=article, longId=869691, objectId=65a9869691d2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250220/1740054122286_8538692.jpg, objectUrl=/article/show_article.do?id=65a9869691d2, replyNumber=0, likeNumber=44, createdTime=2025-04-03, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65a9869691d2, moduleTitle=Cancer Res：中山大學(xué)黃斌/陳凌武/毛曉鵬/陳俊星研究發(fā)現(xiàn)靶向MTHFD2有望成為克服舒尼替尼耐藥性的有效策略, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=65a9869691d2)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-04-03
